Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisako Kayama

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Cancer Immunology, Immunotherapy : CII|June 14, 2022
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemiaNatsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, et al.
Annals of the Rheumatic Diseases|April 3, 2021
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositisNaoko Okiyama, Yuki Ichimura, Miwako Shobo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2012
Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitisHisako Kayama, Yoshiyasu Ueda, Yukihisa Sawa, et al.
Biochemical and Biophysical Research Communications|June 3, 2023
TRAF6 signaling in dendritic cells plays protective role against infectious colitis by limiting C. rodentium infection through the induction of Th1 and Th17 responsesThanyakorn Chalalai, Naganori Kamiyama, Benjawan Saechue, et al.
International Immunology|May 12, 2026
The IL-10/IL-10Rα axis in fibroblasts limits large intestinal pathology by suppressing type I interferon signalingTakayoshi Ito, Bo Li, Taiki Sakaguchi, et al.
Cancer Immunology Research|April 2, 2020
Human NKp44<sup>+</sup> Group 3 Innate Lymphoid Cells Associate with Tumor-Associated Tertiary Lymphoid Structures in Colorectal CancerAtsuyo Ikeda, Takayuki Ogino, Hisako Kayama, et al.
International Immunology|January 8, 2025
Intestinal Foxl1+ cell-derived CXCL12 maintains epithelial homeostasis by modulating cellular metabolismMayu Yagita-Sakamaki, Takayoshi Ito, Taiki Sakaguchi, et al.
The Journal of Experimental Medicine|June 15, 2011
ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18Masahiro Yamamoto, Ji Su Ma, Christina Mueller, et al.
Gastroenterology|September 3, 2013
Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's diseaseTakayuki Ogino, Junichi Nishimura, Soumik Barman, et al.
Mucosal Immunology|July 7, 2016
Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186Kosuke Fujimoto, Makoto Kinoshita, Hiroo Tanaka, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|June 14, 2022
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemiaNatsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, et al.
Annals of the Rheumatic Diseases|April 3, 2021
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositisNaoko Okiyama, Yuki Ichimura, Miwako Shobo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2012
Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitisHisako Kayama, Yoshiyasu Ueda, Yukihisa Sawa, et al.
Biochemical and Biophysical Research Communications|June 3, 2023
TRAF6 signaling in dendritic cells plays protective role against infectious colitis by limiting C. rodentium infection through the induction of Th1 and Th17 responsesThanyakorn Chalalai, Naganori Kamiyama, Benjawan Saechue, et al.
International Immunology|May 12, 2026
The IL-10/IL-10Rα axis in fibroblasts limits large intestinal pathology by suppressing type I interferon signalingTakayoshi Ito, Bo Li, Taiki Sakaguchi, et al.
Cancer Immunology Research|April 2, 2020
Human NKp44<sup>+</sup> Group 3 Innate Lymphoid Cells Associate with Tumor-Associated Tertiary Lymphoid Structures in Colorectal CancerAtsuyo Ikeda, Takayuki Ogino, Hisako Kayama, et al.
International Immunology|January 8, 2025
Intestinal Foxl1+ cell-derived CXCL12 maintains epithelial homeostasis by modulating cellular metabolismMayu Yagita-Sakamaki, Takayoshi Ito, Taiki Sakaguchi, et al.
The Journal of Experimental Medicine|June 15, 2011
ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18Masahiro Yamamoto, Ji Su Ma, Christina Mueller, et al.
Gastroenterology|September 3, 2013
Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's diseaseTakayuki Ogino, Junichi Nishimura, Soumik Barman, et al.
Mucosal Immunology|July 7, 2016
Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186Kosuke Fujimoto, Makoto Kinoshita, Hiroo Tanaka, et al.
Pageof 8